Like BlueBee

closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/16/2012 via BusinessWire

Tegal Corporation, acquired CollabRX, Inc

synopsis: Tegal Corporation announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine.
buyer: Tegal Corporation (TGAL:$0.02)
Tegal Corporation's legacy is evident in the most advanced consumer and industrial products that incorporate microprocessors, magnetic memories, radio frequency ID chips, acoustic wave devices, sensors, LEDs, and an array of other semiconductor and MEMS devices. "
target: CollabRX, Inc (CM:CLRX:$0.38)
CollabRx offers cloud-based expert systems that provide clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision making.
price ($mm)
$1.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/10/2020 via PR Web

HealthLytix merged with Cortechs Labs Inc,

synopsis: CorTechs Labs Inc., the leading quantitative neuroimaging software company, announced that it has merged with sister company HealthLytix, a healthcare technology company developing new applications in genetics and medical imaging to improve the screening and early detection of cancer and neurodegenerative diseases.
buyer: Cortechs Labs Inc
CorTechs Labs is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so people can enjoy longer, better lives. "
target: HealthLytix
HealthLytix is a precision health company and developer of quantitative medical imaging solutions that leverage machine learning. HealthLytix creates data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PR Newswire

InVitae, acquired CancerGene Connect

synopsis: Invitae Corporation, one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare software, including CancerGene Connect, one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories.
buyer: InVitae (NVTA:$216.82)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: CancerGene Connect
CancerGene Connect is one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories. CancerGene Connect was developed by clinicians for clinicians to streamline the collection, analysis, and management of patient family history information.
price ($mm)
$6.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2018 via BusinessWire

Illumina, Inc., acquired Edico Genome Inc.

synopsis: Illumina, Inc.  announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing. Edico Genome’s DRAGEN Bio-IT Platform uses field programmable gate array technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: Edico Genome Inc.
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Their vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2016 via BusinessWire

PierianDx, acquired Tute Genomics

synopsis: PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx’s goal to be the most comprehensive, integrated platform to enable personalized medicine for clinical labs.
buyer: PierianDx
Founded in 2011, PierianDx is the leading provider of genomic software. They enable health systems, academic medical centers and commercial labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. "
target: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$0.00)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/18/2019 via BNC Analysis

NVIDIA Corporation, acquired Parabricks

synopsis: Computational technology company Nvidia has acquired sequencing analysis software developer Parabricks. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
buyer: NVIDIA Corporation (NVDA:$10,918.00)
NVIDIA Corporation is the worldwide leader in programmable graphics processor technologies. The Company creates innovative, industry-changing products for computing, consumer electronics, and mobile devices. "
target: Parabricks
Parabricks is a sequencing analysis software developer. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (ENXTPA:BIM:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2020 via PR Newswire

InVitae, acquired Diploid

synopsis: Invitae Corporation, a leading medical genetics company, has acquired Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
buyer: InVitae (NVTA:$216.82)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Diploid
Belgium-based Diploid provides clinical labs, hospitals, and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform uses AI software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
price ($mm)
$95
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/30/2015 via PR Newswire

Human Longevity, Inc., acquired Cypher Genomics

synopsis: Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.
buyer: Human Longevity, Inc.
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and learning to make novel discoveries to revolutionize the practice of medicine. "
target: Cypher Genomics
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

Ambry Genetics, acquired Progeny Software Inc.

synopsis: Ambry Genetics announced the acquisition of Progeny Software, LLC. This acquisition marries the premier clinical genetics laboratory with the gold standard pedigree software company, effectively redefining Ambry as a complete genetics services company on the forefront of personalized medicine.
buyer: Ambry Genetics
Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy and unparalleled service. "
target: Progeny Software Inc.
Progeny has increasingly enhanced the technology required to manage all types of genetic data. Whether it be related to pedigrees, providing genotype management and analysis, or providing a full LIMS system, Progeny is committed to bring solutions to the table for the customers they serve.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2018 via PR Newswire

Sophia Genetics, acquired Interactive Biosoftware

synopsis: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic data interpretation. Alamut® is currently deployed in over 450 hospitals.
buyer: Sophia Genetics
Based in Switzerland, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. "
target: Interactive Biosoftware
Interactive Biosoftware was founded in Rouen, France, by a group of medical and computer scientists focusing on practical software applications for health care and life sciences, particularly in the field of genomics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/2/2015 via PR Newswire

Tute Genomics, acquired Knome, Inc.

synopsis: Tute Genomics, the leader in clinical sequencing infomatics, announced its acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commericial advancements in modern human genetics.
buyer: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights. "
target: Knome, Inc.
Knome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/18/2019 via BNC Analysis

Verogen, acquired GEDmatch

synopsis: Forensic genomics company Verogen has acquired GEDmatch, a genomics database and genealogy firm. GEDmatch allows users to upload genetic profiles created by other genealogy sites in order to search for familial links. Their database has more than 1.3 million customer profiles and is gaining up to 1,000 new users daily.
buyer parent: Illumina, Inc.
buyer: Verogen
Verogen is the world’s first sequencing company solely dedicated to forensic science. Verogen develops, manufactures, and sells products and services to help unlock the true potential of forensic genomics. Their products include a forensic genomics system, analysis software, reagents, and more. "
target: GEDmatch
GEDmatch is a genomics database and genealogy firm. GEDmatch allows users to upload genetic profiles created by other genealogy sites in order to search for familial links. Their database has more than 1.3 million customer profiles and is gaining up to 1,000 new users daily.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2018 via BusinessWire

Illumina, Inc., acquired Edico Genome Inc.

synopsis: Illumina, Inc.  announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing. Edico Genome’s DRAGEN Bio-IT Platform uses field programmable gate array technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: Edico Genome Inc.
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Their vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/1/2015 via BusinessWire

Illumina, Inc., acquired GenoLogics Life Sciences Software Inc.

synopsis: Illumina, Inc. announced it has completed the acquisition of GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations. This acquisition demonstrates Illumina’s commitment to drive the adoption of sequencing in new markets and improve the genomic workflow.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: GenoLogics Life Sciences Software Inc.
GenoLogics develops the industry-leading laboratory information management system (LIMS) for life sciences organizations. Clarity LIMS helps labs gain efficiencies and throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2013 via Company Press Release

Illumina, Inc., acquired NextBio, Inc.

synopsis: Illumina, Inc. has acquired Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. They provide innovative sequencing and array-based solutions. "
target: NextBio, Inc.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/31/2015 via PR Newswire

Nuvon, Inc. will be merged with Bernoulli Enterprise, Inc.,

synopsis: Cardiopulmonary Corp., a leader in real-time connected healthcare and Nuvon, a leader in medical device integration, interoperability, and clinical intelligence, announced that they have entered into a definitive agreement for Nuvon to merge with Cardiopulmonary Corp.
buyer: Bernoulli Enterprise, Inc.
Cardiopulmonary Corp. is a leader in real-time connected healthcare. Its flagship Bernoulli Enterprise system provides a platform for Medical Device Connectivity, Alarm Management, Virtual ICU and Analytics to enable better outcomes, reduce the cost of care and improve patient/staff satisfaction. "
target: Nuvon, Inc.
Nuvon's mission is to transform medicine by delivering critical Patient Care Data at the point of care. Nuvon's FDA cleared Class I and Class II Medical Device Connectivity and Clinical Intelligence Systems connect and automates the capture of Patient Care Data from medical devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via BNC Analysis

B.Braun Medical Inc., acquired BPMpathway

synopsis: B. Braun, one of the world’s leading manufacturers of medical devices and pharmaceutical products, has acquired 270 Vision Limited (BPMpathway), a UK-based developer of wearable sensor technology. BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
buyer: B.Braun Medical Inc.
B. Braun is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. "
target: BPMpathway
BPMpathway (270 Vision Limited) is a UK-based developer of wearable sensor technology. Product design and development company BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2013 via Market Watch

Medtronic, Inc., acquired CardioCom

synopsis: Medtronic, Inc., the global leader in medical technology, announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases, in an all cash transaction valued at $200 million.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. "
target: CardioCom
Cardiocom is a proven leader in Integrated Clinical Telehealth Services. Cardiocom is a world-class developer, manufacturer and clinical telehealth solutions provider with cutting-edge, yet user-friendly telemonitoring products and services.
price ($mm)
$200
rev ($mm)
$50
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 2/13/2020 via Company Press Release

Medtronic, Inc., acquired Digital Surgery

synopsis: Medtronic, the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic is among the world’s largest medical technology, services and solutions companies, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients. "
target: Digital Surgery
Headquartered in London, England, Digital Surgery’s mission is to digitize surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via Company Press Release

Sentrics, acquired Silversphere

synopsis: Sentrics, the emerging industry leader that provides integrated technologies to the senior living industry, announced it has acquired Silversphere. Silversphere delivers a suite of interconnected solutions to senior living communities that detect, alert and predict resident needs that help caregivers deliver proactive care and prevent emergencies.
buyer parent: Periscope Equity
buyer: Sentrics
Sentrics is an integrated system of data-driven technology companies enabling greater transparency into the quality of life for residents, providers and families. Sentrics partners with senior living operators to strengthen focus on the total well-being of each resident. "
target: Silversphere
Silversphere is a senior living specific technology company that, for over 70 years, has been dedicated to improving the lives of seniors and their caregivers. Silversphere designs, manufactures, installs, and supports emergency call systems, nurse call systems, resident monitoring, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2014 via PR Newswire

Henry Schein, Inc., acquired Julie Owandy Group

synopsis: Henry Schein, Inc., the world's largest provider of healthcare products and services, announced the signing of an agreement to acquire five businesses operating in three European countries from Arseus NV. One of the businesses is the leading dental practice management software company in France, Logiciel Julie.
buyer: Henry Schein, Inc. (HSIC:$13,288.81)
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. "
target parent: Arseus NV
target: Julie Owandy Group
Owandy is an international player and is renowned for manufacturing dental imaging solutions and developing imaging and practice management software. Its software is used by around half of the dental practitioners in France.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 8/15/2012 via BNC Analysis

Alere, acquired MedApps, Inc.

synopsis: Waltham, Massachusetts-based Alere acquired wireless remote patient monitoring company MedApps. MedApps is dedicated to developing innovative remote health monitoring solutions that deliver efficient cost-effective connectivity between patient, care provider and electronic medical records.
buyer: Alere (ALR:$2,818.83)
Alere provides disease management services by connecting a unique blend of at-home monitoring technology, patient-empowering education, and nurse-patient relations to improve the daily lives people with heart failure. "
target: MedApps, Inc.
MedApps, Inc. develops mobile health monitoring systems. The company’s solutions link patients, families, and healthcare providers using cellular technology to collect, store, and report health information.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/5/2012 via PR Newswire

Varian Medical Systems, Inc., will acquire InfiMed, Inc.

synopsis: Varian Medical Systems, Inc., announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
target: InfiMed, Inc.
Since 1983, InfiMed, Inc. has been a developer of digital medical acquisition, image processing, and sensor solutions. These systems are used in hospital Cath Labs, X-ray departments, imaging centers, and trauma centers worldwide.
price ($mm)
$15
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.0x
EV / EBITDA
announced 5/4/2009 via Company Description

Philips Electronics NV, will acquire Traxtal Inc.

synopsis: Royal Philips Electronics announced that it has acquired Canada-based Traxtal Inc., an innovative medical technology company in the field of minimally-invasive instruments and software for image-guided intervention and therapy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$20,876.84)
Royal Philips Electronics is a global leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions. The company has medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, home appliances, as well as consumer electronics. "
target: Traxtal Inc.
Traxtal, Inc. engages in the development and manufacture of computer assisted soft tissue navigation technologies. It offers PercuNav system, an image-guided diagnostic and interventional system for various imaging modalities.
price ($mm)
$24
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2008 via BNC Analysis

Arseus NV, acquired Julie Owandy Group

synopsis: Advised by Close Brothers, Arseus NV, listed on the Eurolist in Brussels and Amsterdam, has acquired the Julie-Owandy group. Founded in 1997, the Julie-Owandy group is the French leading provider of software for dentists (over 14,000 dentists equipped out of 35,000 in France) and one of the leaders of dental imaging equipment.
buyer: Arseus NV (FAGR:$473.30)
Arseus is a multinational group of companies that provides products, services and concepts for professionals and institutions active in the healthcare sector in Europe. "
target: Julie Owandy Group
Owandy S.A. focuses on specific software and sales of IT equipment. We have introduced the first digital auto-focus camera and cable free sensor UPIX. Our X-ray unit comprises of elios ac and altis dc. The altis dc generator guarantees consistent exposure settings.
price ($mm)[EV]
$34 [$37]
rev ($mm)
$37
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$20,876.84)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2011 via BusinessWire

Ophthalmic Imaging Systems Inc. merged with Merge Healthcare Incorporated,

synopsis: Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems (OIS), one of the country’s top providers of digital imaging and informatics solutions for ophthalmology and other medical specialties, announced the completion of Merge’s acquisition of OIS.
buyer: Merge Healthcare Incorporated (MRGE:$227.59)
Merge Healthcare is the leading provider of enterprise imaging and interoperability solutions. Merge Healthcare solutions facilitate the sharing of images to create a more effective and efficient electronic healthcare experience for patients and physicians. "
target: Ophthalmic Imaging Systems Inc.
Ophthalmic Imaging Systems (OIS) is a provider of ophthalmic digital imaging and informatics systems. OIS designs, develops, manufactures and markets digital imaging systems, image management and integrated electronic medical records and practice management solutions for the eye care market.
price ($mm)[EV]
$29 [$30]
rev ($mm)
$18
EBITDA ($mm)
EV / rev
2.0x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2019 via BNC Analysis

Boots UK Limited, acquired Wiggly-Amps Limited

synopsis: High street retailer Boots has acquired tech company Wiggly-Amps in a bid to boost its stake in the digital healthcare sector. Wiggly-Amps provides a number of online services including check-in screens at GP (general practitioner) surgeries, weight measurements, consultations and prescription services as well as creating and hosting GP websites.
buyer parent: Walgreens Boots Alliance, Inc.
buyer: Boots UK Limited
Boots UK, the UK’s leading pharmacy-led health and beauty retailer, is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc., the first global pharmacy-led, health and wellbeing enterprise. "
target: Wiggly-Amps Limited
Wiggly-Amps provides a number of online services including check-in screens at GP (general practitioner) surgeries, weight measurements, consultations and prescription services as well as creating and hosting GP websites.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2018 via BNC Analysis

MindMaze, acquired Neuro Motor Innovations Corporation

synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer: MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
target: Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/15/2015 via Company Press Release

Straumann, acquired Dental Wings

synopsis: Dental Wings is proud to announce that Straumann has increased its ownership position in Dental Wings from 44% to 55%, with an option to increase to full ownership by 2020. Dental Wings is a leading provider of digital dentistry technologies.
buyer: Straumann (SWX:STMN:$762.03)
Straumann is a leading provider of solutions in implant dentistry and dental tissue regeneration. Their mission is to enable dental professionals to restore their patients’ oral function and esthetics through effective, reliable, and safe treatment methods. "
target: Dental Wings
Dental Wings is a leading provider of digital dentistry technologies. Its solutions cover dental scanning, implant planning, prosthesis design, manufacturing and communication among dental professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like BlueBee


read more

BlueBee

CollabRX, Inc

UNIConnect LC

HealthLytix

CancerGene Connect

Edico Genome Inc.

Tute Genomics

Cytobank

Parabricks

Applied Maths

Diploid

Cypher Genomics

Progeny Software Inc.

Interactive Biosoftware

Knome, Inc.

Geospiza

read more

BlueBee

read more

BlueBee

GEDmatch

Edico Genome Inc.

GenoLogics Life Sciences Software Inc.

NextBio, Inc.

read more

ImPACT Concussion Management

Nuvon, Inc.

BPMpathway

CardioCom

Digital Surgery

MST Medical Surgery Technologies Ltd.

Silversphere

Julie Owandy Group

MedApps, Inc.

InfiMed, Inc.

Traxtal Inc.

Julie Owandy Group

EPD Solutions Ltd.

Ophthalmic Imaging Systems Inc.

BreathResearch

Wiggly-Amps Limited

Neuro Motor Innovations Corporation

Telcare

Dental Wings

Geography
Matching Companies
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch
Ticker: BRKR
 
 
 
 
 
 
 
 
Bruker Corporation
Bruker Corporation
Bruker Corporation is a global manufacturer of high-end analytical instruments used within the academic & government, pharma/biotech, clinical diagnostic, and industrial markets. It operates in the life science tools and diagnostic indsutry.
year
2018
rev ($mm)
$1,925.30
EBITDA ($mm)
$347.10
EBIT ($mm)
$279.00
Net Income ($mm)
$183.50
Employees
6870
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: MASI
 
 
 
 
 
 
 
 
Masimo
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.
year
2019
rev ($mm)
$913.46
EBITDA ($mm)
$234.73
EBIT ($mm)
$213.99
Net Income ($mm)
$190.23
Employees
1500
  • drill down
  • watch
Ticker: ASX:PGC
 
 
 
 
 
 
 
 
Paragon Care
Paragon Care
Paragon Care is a company focused on Hospital & Healthcare services and has progressively acquired businesses in the healthcare sector. It is a leading provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.
year
2018
rev ($mm)
$98.79
EBITDA ($mm)
$9.27
EBIT ($mm)
$8.09
Net Income ($mm)
$7.91
Employees
508
  • drill down
  • watch
Ticker: ENXTPA:ALVMG
 
 
 
 
 
 
 
 
Visiomed Group SA
Visiomed Group SA
Founded in 2007, Visiomed Group is a company that specializes in next-generation medical electronics. The laboratory develops and markets innovative healthcare products in the promising areas of self-diagnosis for medical use and well-being.
year
2017
rev ($mm)
$11.54
EBITDA ($mm)
($16.87)
EBIT ($mm)
($17.34)
Net Income ($mm)
Employees
102
  • drill down
  • watch
Ticker: RMD
 
 
 
 
 
 
 
 
ResMed
ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
year
2019
rev ($mm)
$2,784.41
EBITDA ($mm)
$858.38
EBIT ($mm)
$696.96
Net Income ($mm)
$454.92
Employees
7240
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: XRAY
 
 
 
 
 
 
 
 
Dentsply Sirona
Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide.
year
2017
rev ($mm)
$3,993.40
EBITDA ($mm)
$830.20
EBIT ($mm)
$513.80
Net Income ($mm)
Employees
16100
  • drill down
  • watch
Ticker: ALOG
 
 
 
 
 
 
 
 
Analogic Corporation
Analogic Corporation
Analogic provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. They are recognized for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection.
year
2015
rev ($mm)
$536.92
EBITDA ($mm)
$63.82
EBIT ($mm)
$40.72
Net Income ($mm)
$31.20
Employees
1679
  • drill down
  • watch
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: OTCPK:ECSL
 
 
 
 
 
 
 
 
Encounter Care Solutions, Inc.
Encounter Care Solutions, Inc.
Encounter Care Solutions, Inc. offer integrated web-based applications with enabling technologies that transform the delivery of healthcare and the management of data for healthcare providers and consumers.
year
2011
rev ($mm)
$0.56
EBITDA ($mm)
($0.28)
EBIT ($mm)
($0.32)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ISRG
 
 
 
 
 
 
 
 
Intuitive Surgical
Intuitive Surgical
Intuitive, headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, they believe that minimally invasive care is life-enhancing care.
year
2019
rev ($mm)
$4,478.50
EBITDA ($mm)
$1,575.00
EBIT ($mm)
$1,375.30
Net Income ($mm)
$1,379.30
Employees
7326
  • drill down
  • watch
Ticker: SPA
 
 
 
 
 
 
 
 
Sparton Corporation
Sparton Corporation
Sparton Corporation, now in its 115th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service, and refurbishment.
year
2014
rev ($mm)
$338.86
EBITDA ($mm)
$32.07
EBIT ($mm)
$23.21
Net Income ($mm)
$10.89
Employees
1385
  • drill down
  • watch
Ticker: SGN
 
 
 
 
 
 
 
 
Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring.
year
2007
rev ($mm)
EBITDA ($mm)
($14.36)
EBIT ($mm)
($14.46)
Net Income ($mm)
Employees
15
  • drill down
  • watch